Cargando…

BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

OBJECTIVES: Dendritic cells play a pivotal but still enigmatic role in the control of tumor development. Composed of specialised subsets (cDC1s, cDC2s, pDCs), DCs are critical in triggering and shaping antitumor immune responses. Yet, tumors exploit plasticity of DCs to subvert their functions and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosa Cuevas, Eleonora, Ouaguia, Laurissa, Mouret, Stephane, Charles, Julie, De Fraipont, Florence, Manches, Olivier, Valladeau‐Guilemond, Jenny, Bendriss‐Vermare, Nathalie, Chaperot, Laurence, Aspord, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684973/ https://www.ncbi.nlm.nih.gov/pubmed/33282290 http://dx.doi.org/10.1002/cti2.1190

Ejemplares similares

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs
por: Ouaguia, Laurissa, et al.
Publicado: (2020)

Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80(+) PDL1(−))‐pDC subset negatively correlated with clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022)

Metabolomic and lipidomic signatures associated with activation of human cDC1 (BDCA3(+)/CD141(+)) dendritic cells
por: Basit, Farhan, et al.
Publicado: (2021)

Characterization of BDCA1 and BDCA4 dendritic cell subsets in rheumatoid arthritis patients
por: Lebre, MC, et al.
Publicado: (2004)

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022)

Paramyxovirus Infection Regulates T Cell Responses by BDCA-1(+) and BDCA-3(+) Myeloid Dendritic Cells
por: Gupta, Meera R., et al.
Publicado: (2014)

Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo
por: Wrzesinski, Stephen H, et al.
Publicado: (2013)

Differential response of BDCA-1(+) and BDCA-3(+) myeloid dendritic cells to respiratory syncytial virus infection
por: Gupta, Meera R, et al.
Publicado: (2013)

Re-evaluation of human BDCA-2(+) DC during acute sterile skin inflammation
por: Chen, Yi-Ling, et al.
Publicado: (2019)

Enterovirus-Infected β-Cells Induce Distinct Response Patterns in BDCA1(+) and BDCA3(+) Human Dendritic Cells
por: Schulte, Barbara M., et al.
Publicado: (2015)

Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
por: Jongbloed, Sarah L., et al.
Publicado: (2010)

Mouse CD8α(+) DCs and human BDCA3(+) DCs are major producers of IFN-λ in response to poly IC
por: Lauterbach, Henning, et al.
Publicado: (2010)

Human BDCA2(+)CD123(+)CD56(+) dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset
por: Yu, Haisheng, et al.
Publicado: (2015)

Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation
por: Mandl, Manuela, et al.
Publicado: (2015)

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
por: van Ee, Thomas J., et al.
Publicado: (2018)

Mutations in bdcA and valS Correlate with Quinolone Resistance in Wastewater Escherichia coli
por: Malekian, Negin, et al.
Publicado: (2021)

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes
por: Girard, Pauline, et al.
Publicado: (2021)

Escherichia coli BdcA controls biofilm dispersal in Pseudomonas aeruginosa and Rhizobium meliloti
por: Ma, Qun, et al.
Publicado: (2011)

Intratumoral administration of CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
por: Schwarze, Julia Katharina, et al.
Publicado: (2022)

TLR3 Signaling Promotes the Induction of Unique Human BDCA-3 Dendritic Cell Populations
por: Colletti, Nicholas J., et al.
Publicado: (2016)

The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function
por: van der Aa, Evelyn, et al.
Publicado: (2016)

Differential Susceptibility and Response of Primary Human Myeloid BDCA1(+) Dendritic Cells to Infection with Different Enteroviruses
por: Schulte, Barbara M., et al.
Publicado: (2013)

Accumulation of BDCA1(+) Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma
por: Greer, Alexandra M., et al.
Publicado: (2014)

Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus
por: Gardet, Agnes, et al.
Publicado: (2019)

The Superior Ability of Human BDCA3(+) (CD141(+)) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
por: Gu, Fei-fei, et al.
Publicado: (2020)

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3(+) dendritic cells at cross presentation
por: Cohn, Lillian, et al.
Publicado: (2013)

Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage
por: Bajana, Sandra, et al.
Publicado: (2020)

Characterization of human DNGR-1(+) BDCA3(+) leukocytes as putative equivalents of mouse CD8α(+) dendritic cells
por: Poulin, Lionel Franz, et al.
Publicado: (2010)

CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3(+) Dendritic Cells and a Subset of Monocytes
por: Huysamen, Cristal, et al.
Publicado: (2008)

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
por: Pellerin, Alex, et al.
Publicado: (2015)

Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019)

BDCA2/FcɛRIγ Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells
por: Cao, Wei, et al.
Publicado: (2007)

Expression of the T Cell Receptor αβ on a CD123+ BDCA2+ HLA-DR+ Subpopulation in Head and Neck Squamous Cell Carcinoma
por: Thiel, Annette, et al.
Publicado: (2011)

BdcA, a Protein Important for Escherichia coli Biofilm Dispersal, Is a Short-Chain Dehydrogenase/Reductase that Binds Specifically to NADPH
por: Lord, Dana M., et al.
Publicado: (2014)

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1(+) Myeloid Dendritic Cells
por: Kalus, Philipp, et al.
Publicado: (2022)

cDC1 dysregulation in cancer: An opportunity for intervention
por: Gajewski, Thomas F., et al.
Publicado: (2020)

Resident CD141 (BDCA3)(+) dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
por: Chu, Chung-Ching, et al.
Publicado: (2012)

Big data, cloud and applications: third international conference, BDCA 2018, Kenitra, Morocco, April 4-5, 2018, revised selected papers
por: Tabii, Youness, et al.
Publicado: (2018)

Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma
por: Ross, Rebecca L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4frnk5akbt6q87pe3q8oi1952t